Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) is a prescription drug used to manage COPD in adults. Breztri Aerosphere’s cost may depend on ...

One of these new inhalers is called Breztri Aerosphere. You may hear this called “triple therapy.” COPD is a long-term (or chronic) condition of the lungs that can make it hard to breathe.

BREZTRI AEROSPHERE 160/7.2/5 (AUST R 339070) and BREZTRI AEROSPHERE 160/7.2/5 DFP-EvoCap (AUST R 386646) come in two pack sizes* - 120 actuations (puffs) inhaler and a 28 actuations (puffs ...

AstraZeneca will present full data at an upcoming meeting. Breztri Aerosphere, a triple inhaled therapy, met its primary endpoint of lung function improvement in adults and adolescents with ...

BREZTRI, already approved in over 80 countries for chronic obstructive pulmonary disease (COPD), may now offer hope to asthma sufferers. “We are excited by the positive results from the KALOS ...

Breztri is an inhaled triple-combination therapy approved for chronic obstructive pulmonary disease (COPD) in adults in more than 80 countries worldwide, including the US, EU, China, and Japan.

WILMINGTON, Del., May 02, 2025--(BUSINESS WIRE)--Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that AstraZeneca’s fixed-dose ...

May 2 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Friday its triple-combination inhaler Breztri Aerosphere met all main goals in two late-stage trials for uncontrolled asthma ...

KALOS and LOGOS were replicate, randomized, double-blind trials designed to investigate BREZTRI as a potential treatment for asthma. 1,2 The trials evaluated the efficacy and safety of BREZTRI ...

Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that AstraZeneca’s fixed-dose triple-combination therapy BREZTRI AEROSPHERE ...